TORNTPHARM — Torrent Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Torrent Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	80,048	85,080	96,202	107,278	115,160
Cost of Revenue
Gross Profit	57,695	59,706	67,925	79,401	87,400
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	61,769	72,236	74,847	81,685	86,140
Operating Profit	18,279	12,844	21,355	25,594	29,020
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	15,263	12,259	18,472	23,521	26,730
Provision for Income Taxes
Net Income After Taxes	12,519	7,772	12,452	16,564	19,110
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	12,519	7,772	12,452	16,564	19,110
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12,519	7,772	12,452	16,564	19,110
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	37	32	36.5	47.4	57
Dividends per Share
Special Dividends per Share